UroNova GmbH

25/10/2022

Have a look at cleanus.org to learn more about UroNova's clinical study at the University of Rostock about latest technology to suppress encrustation of ureteral stents!

12/10/2021

UroNova's unique coating technology reduces bacterial adhesion, biofilm formation and encrustation on urological stents and catheters without releasing substances into the human body or promoting bacterial resistance. The coating is long-term stable and keeps its efficiency even over prolonged periods up to one year.
Watch our animated video explaining how it works!

30/04/2020

Infection, encrustation and blockage of long-term indwelling catheters, ureteral stents and nephrostomy tubes are significant medical and health-economic problems. Because of these problems, about 50% of patients with permanent urinary drainage devices present as emergency cases during their course of disease, 13000 patients die and up to 1.3 Billion Euro additional costs are produced per year in Western Europe and a similar amount in North America.

Commonly urinary tract infections are treated with antibiotics. But the wide use of antibiotic medication harbours the risk of promoting bacterial resistances. Resistant bacteria can't be effectively treated by antibiotics anymore to help critically ill patients. Also coatings using antibiotics, silver and other biozides can lead to resistances.

UroNova's unique patented technology protects stents and catheters from bacterial biofilm formation and subsequent encrustation without using antibioctics, silver particels or any other biozide substance. Proven, hundred-thousandfold in clinical every-day practice.

No drug elution takes place, so no systemic side effects are caused. The coating's effectiveness is not limited in time, as it is long-term stable. Biocompatibility is unparalleled.

30/04/2020

Interested in examples of existing products with UroNova's coatings?
The Longlife silicone balloon catheter is distributed by Uronovis (www.uronovis.de) in Germany and Medinovis (www.medinovis.nl) in the Netherlands.
The endoSof Radiance ureteral stent is sold globally by Cook medical (www.cookmedical.com).

URONOVIS - Ihr Partner Als dynamisches Unternehmen hat sich die Uronovis GmbH auf den urologischen Markt spezialisiert. Hier bringen wir unser ganzes Wissen ein, um neue Produkte zu entwickeln und bestehende konsequent zu optimieren. Dabei setzen wir auch die vielen Erkenntnisse um, die wir aus dem....

30/04/2020

UroNova was awarded with the prestigious Global Health & Pharma Technology Awards 2019.
GHP Magazine’s Technology Awards programme was launched to recognise those that are forging the future of healthcare through innovative adoption of technological advancements. All recognised winners have made important contributions to their field as they look to improve, enhance and perfect patient care.
Learn more about the reasons for awarding UroNova:
https://www.ghp-news.com/issues/technology-awards-2019/19/